WT cells treated with either EGF or DFMO had high degrees of activated EGFR, ERK1/2, Src, and AKT while judged from the degrees of their phosphorylated forms (Fig

WT cells treated with either EGF or DFMO had high degrees of activated EGFR, ERK1/2, Src, and AKT while judged from the degrees of their phosphorylated forms (Fig. aftereffect of DFMO. Furthermore, inhibition of integrin 3 activity (with RGDS), Src activity (with PP2), or EGFR kinase activity (with AG1478), improved…